Literature DB >> 8783770

Studies of insulin resistance in congenital generalized lipodystrophy.

O Søvik1, H Vestergaard, O Trygstad, O Pedersen.   

Abstract

Two well-characterized patients with congenital, generalized lipodystrophy have been studied by the euglycaemic hyperinsulinaemic clamp technique in combination with indirect calorimetry. Furthermore, glycogen synthase in muscle biopsies was studied in one patient with regard to enzyme activity, immunoreactive protein and mRNA levels. The patients had fasting hyperinsulinaemia, and the rate of total glucose disposal was severely impaired, primarily due to a decreased non-oxidative glucose metabolism. In the patient studied with muscle biopsy, the expected activation of glycogen synthase by insulin did not occur. In both patients there was severely increased hepatic glucose output in the basal state, suggesting a failure of insulin to suppress hepatic gluconeogenesis. During insulin infusion a substantially elevated rate of lipid oxidation remained in the patients, in contrast to the almost completely suppressed lipid oxidation in the controls. It is concluded that patients with congenital generalized lipodystrophy may present severe insulin resistance with regard to hepatic glucose production as well as muscle glycogen synthesis and lipid oxidation. The results suggest a postreceptor defect in the action of insulin in congenital generalized lipodystrophy. The further localization of such a defect is hampered by the still incomplete understanding of the pathways that link insulin-stimulated tyrosine phosphorylation to the ultimate action of insulin upon target cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783770     DOI: 10.1111/j.1651-2227.1996.tb14263.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  4 in total

Review 1.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 2.  RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27.

Authors:  V Puri; J V Virbasius; A Guilherme; M P Czech
Journal:  Acta Physiol (Oxf)       Date:  2008-01       Impact factor: 6.311

3.  Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects.

Authors:  Mao Fu; Rasa Kazlauskaite; Maria de Fátima Paiva Baracho; Maria Goretti Do Nascimento Santos; José Brandão-Neto; Sandra Villares; Francesco S Celi; Bernardo L Wajchenberg; Alan R Shuldiner
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 4.  Obesity and cancer, a case for insulin signaling.

Authors:  Y Poloz; V Stambolic
Journal:  Cell Death Dis       Date:  2015-12-31       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.